SE7711053L - HYDANTOINDERIVAT - Google Patents
HYDANTOINDERIVATInfo
- Publication number
- SE7711053L SE7711053L SE7711053A SE7711053A SE7711053L SE 7711053 L SE7711053 L SE 7711053L SE 7711053 A SE7711053 A SE 7711053A SE 7711053 A SE7711053 A SE 7711053A SE 7711053 L SE7711053 L SE 7711053L
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- compounds obtained
- medicaments
- formulae
- yields
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The compounds of formulae I to V - the meaning of the symbols is explained in Claim 1 - are prepared by a reaction of the starting carbonyl compound with simultaneously an alkali metal cyanide and ammonium carbonate. The yields are very good. If desired, the salts of the compounds obtained with pharmaceutically acceptable cations are formed. The compounds obtained can be used as medicaments for combating certain chronic complications resulting from alimentary diabetes. <IMAGE>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73306276A | 1976-10-18 | 1976-10-18 | |
| US05/767,803 US4117230A (en) | 1976-10-18 | 1977-02-11 | Hydantoin derivatives as therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7711053L true SE7711053L (en) | 1978-04-19 |
| SE437024B SE437024B (en) | 1985-02-04 |
Family
ID=27112515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7711053A SE437024B (en) | 1976-10-18 | 1977-10-03 | PROCEDURE FOR THE PREPARATION OF SPIRO-HYDANTO COMPOUNDS |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5353653A (en) |
| AR (1) | AR220901A1 (en) |
| AT (1) | AT356136B (en) |
| AU (1) | AU504978B2 (en) |
| BG (1) | BG28847A3 (en) |
| CA (1) | CA1088945A (en) |
| CH (1) | CH625511A5 (en) |
| DD (1) | DD131931A5 (en) |
| DE (4) | DE2746244C2 (en) |
| DK (1) | DK150302C (en) |
| ES (1) | ES463267A1 (en) |
| FI (1) | FI62307C (en) |
| FR (1) | FR2367754A1 (en) |
| GB (1) | GB1566171A (en) |
| GR (1) | GR70201B (en) |
| HK (1) | HK53881A (en) |
| IE (1) | IE45805B1 (en) |
| IL (1) | IL53094A0 (en) |
| KE (1) | KE3167A (en) |
| LU (1) | LU78330A1 (en) |
| MX (1) | MX4899E (en) |
| MY (1) | MY8200157A (en) |
| NL (1) | NL167434C (en) |
| NO (1) | NO148453C (en) |
| NZ (1) | NZ185358A (en) |
| PH (1) | PH15639A (en) |
| PT (1) | PT67164B (en) |
| SE (1) | SE437024B (en) |
| YU (1) | YU40821B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
| US4283409A (en) * | 1979-10-29 | 1981-08-11 | Pfizer Inc. | Imidazolone derivatives |
| US4286098A (en) * | 1980-03-28 | 1981-08-25 | Pfizer Inc. | Process for the preparation of chiral hydantoins |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| DE3262294D1 (en) * | 1981-05-13 | 1985-03-28 | Ici Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
| JPS58213717A (en) * | 1982-01-20 | 1983-12-12 | Eisai Co Ltd | Remedy containing hydantoin derivative |
| JPS59500617A (en) * | 1982-04-15 | 1984-04-12 | アルコン・ラボラトリ−ズ・インコ−ポレ−テッド | Hydantoin therapeutic agent |
| SU1380610A3 (en) * | 1982-12-06 | 1988-03-07 | Пфайзер Инк. (Фирма) | Method of producing spiroheteroazolydindiones or pharmaceutically acceptable salts thereof |
| US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
| WO1986002647A1 (en) * | 1984-10-30 | 1986-05-09 | Pfizer Inc. | Spiro-heteroazolones for treatment of diabetes complications |
| JPS61200991A (en) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient |
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| JPS6357588A (en) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | Hydantoin derivative, salt and, production thereof and preventing and treating, agent for diabetic complication |
| HU204832B (en) * | 1987-09-04 | 1992-02-28 | Pfizer | Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| WO2003088915A2 (en) | 2002-04-18 | 2003-10-30 | University Of Virginia Patent Foundation | Novel sodium channel blockers |
| FR2955107B1 (en) | 2010-01-08 | 2012-03-02 | Servier Lab | NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB818724A (en) * | 1956-10-18 | 1959-08-19 | Ici Ltd | Hydantoin derivatives |
| DE1135915B (en) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Process for the production of new, anticonvulsant spirohydantoins |
| US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
| US3821383A (en) | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| DE2449030A1 (en) * | 1974-10-11 | 1976-05-20 | Schering Ag | NEW PYRIDINE DERIVATIVES |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
-
1977
- 1977-09-30 CA CA287,868A patent/CA1088945A/en not_active Expired
- 1977-10-03 SE SE7711053A patent/SE437024B/en not_active IP Right Cessation
- 1977-10-04 GR GR54503A patent/GR70201B/el unknown
- 1977-10-05 NZ NZ185358A patent/NZ185358A/en unknown
- 1977-10-06 AU AU29431/77A patent/AU504978B2/en not_active Expired
- 1977-10-10 YU YU2442/77A patent/YU40821B/en unknown
- 1977-10-10 IL IL53094A patent/IL53094A0/en not_active IP Right Cessation
- 1977-10-14 DE DE2746244A patent/DE2746244C2/en not_active Expired
- 1977-10-14 PH PH20335A patent/PH15639A/en unknown
- 1977-10-14 FI FI773060A patent/FI62307C/en not_active IP Right Cessation
- 1977-10-14 DE DE2759543A patent/DE2759543C2/en not_active Expired
- 1977-10-14 DE DE2759927A patent/DE2759927C2/en not_active Expired
- 1977-10-14 DE DE2759542A patent/DE2759542C2/de not_active Expired
- 1977-10-15 ES ES463267A patent/ES463267A1/en not_active Expired
- 1977-10-17 IE IE2114/77A patent/IE45805B1/en not_active IP Right Cessation
- 1977-10-17 MX MX776490U patent/MX4899E/en unknown
- 1977-10-17 CH CH1262677A patent/CH625511A5/en not_active IP Right Cessation
- 1977-10-17 LU LU78330A patent/LU78330A1/en unknown
- 1977-10-17 PT PT67164A patent/PT67164B/en unknown
- 1977-10-17 DK DK461377A patent/DK150302C/en not_active IP Right Cessation
- 1977-10-17 GB GB43122/77A patent/GB1566171A/en not_active Expired
- 1977-10-17 NL NL7711358.A patent/NL167434C/en not_active IP Right Cessation
- 1977-10-17 NO NO773548A patent/NO148453C/en unknown
- 1977-10-17 JP JP12437177A patent/JPS5353653A/en active Granted
- 1977-10-17 FR FR7731216A patent/FR2367754A1/en active Granted
- 1977-10-18 BG BG037604A patent/BG28847A3/en unknown
- 1977-10-18 AR AR269623A patent/AR220901A1/en active
- 1977-10-18 AT AT745977A patent/AT356136B/en not_active IP Right Cessation
- 1977-10-18 DD DD7700201582A patent/DD131931A5/en unknown
-
1978
- 1978-11-25 JP JP53145925A patent/JPS5940388B2/en not_active Expired
- 1978-11-25 JP JP53145926A patent/JPS607997B2/en not_active Expired
-
1981
- 1981-10-09 KE KE3167A patent/KE3167A/en unknown
- 1981-11-05 HK HK538/81A patent/HK53881A/en unknown
-
1982
- 1982-12-30 MY MY157/82A patent/MY8200157A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7711053L (en) | HYDANTOINDERIVAT | |
| GB1250538A (en) | ||
| ES413260A1 (en) | Nn * 11 chikan 33 pirorijiniru * chiobenzuamidono seiho | |
| JPS5347515A (en) | Gamma-globulin pharmaceutical preparation for intravenous injection | |
| JPS5233682A (en) | Preparation of 1,3-bis(2'-tetrahydrofuryl)-5-flurouracil | |
| ES446187A1 (en) | Oxime ethers having anti-depressive activity | |
| JPS5295674A (en) | Preparation of 4#-substituted-2-methyl-2-piperidinopropiophenone and i ts salts | |
| JPS539730A (en) | Preparation of optical active n-substituted diarylsulfinylimines | |
| JPS51115402A (en) | Process for preparation of alpha-amino acid | |
| DE3265652D1 (en) | Novel compound having analgesic, antiinflammatory and antipyretic activity, process for its preparation and pharmaceutical compositions containing it | |
| FR2081496A1 (en) | Antiinflammatory and analgesic benzo-thieno-pyrimidine - deriv | |
| JPS52102219A (en) | Preparation of glycosides | |
| FR2129914A2 (en) | Sulphonic acid salts of aliphatic diamines - with antiviral activity | |
| ES360153A1 (en) | Procedure for the preparation of bencilideno-amido-hidracinas. (Machine-translation by Google Translate, not legally binding) | |
| GB1482047A (en) | Bicyclohexane derivatives for use in the synthesis of prostaglandins | |
| JPS5236663A (en) | Preparation of 3-chloro-1,2- benzoisothiazole-1,1-dioxide | |
| JPS5271448A (en) | Synthesis of 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxy-cyclohex- 2-enone | |
| JPS52156863A (en) | Preparation of 1-methyl-2,3,5,6-tetrahydro-3-hydroxy-5-semicarbazono-6-oxoindole | |
| JPS5312830A (en) | Preparation of dinitrodiphenyl ether | |
| ES420666A1 (en) | (1-methyl-5-nitro-2-imidazolyl)thioalkanoic acids and derivatives | |
| JPS5283386A (en) | Synthesis of n1-(2,-furanidyl)-5-fluorouracil | |
| JPS52139002A (en) | Synthesis of glydicyl esters of carboxylic acids | |
| JPS532476A (en) | Synthesis of 4-substituted-dithio-2-azetidinone derivatives | |
| JPS5265236A (en) | Preparation of hydroquinone derivatives | |
| JPS5253812A (en) | Preparation of perfluorocarboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7711053-4 Effective date: 19940510 Format of ref document f/p: F |